JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.095x

Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has a cash flow conversion efficiency ratio of 0.095x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.62 Billion ≈ $39.19 Million USD) by net assets (Rs38.06 Billion ≈ $411.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

JB Chemicals & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how JB Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) financial obligations for a breakdown of total debt and financial obligations.

JB Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jiangsu Changshu Rural Commercial Bank Co Ltd
SHG:601128
0.065x
Chunghwa Precision Test Tech Co Ltd
TWO:6510
0.053x
IGO LTD SP.ADR/2
F:IDZ1
N/A
NCsoft Corp
KO:036570
0.009x
iRay Technology Co Ltd
SHG:688301
0.057x
Endurance Technologies Limited
NSE:ENDURANCE
0.105x
Gibson Energy Inc.
TO:GEI
0.171x
Centrus Energy Corp.
NYSE MKT:LEU
-0.063x

Annual Cash Flow Conversion Efficiency for JB Chemicals & Pharmaceuticals Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market value of JB Chemicals & Pharmaceuticals Limited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs34.33 Billion
≈ $371.30 Million
Rs9.02 Billion
≈ $97.60 Million
0.263x -4.02%
2024-03-31 Rs29.23 Billion
≈ $316.15 Million
Rs8.01 Billion
≈ $86.58 Million
0.274x +8.58%
2023-03-31 Rs24.80 Billion
≈ $268.24 Million
Rs6.26 Billion
≈ $67.66 Million
0.252x +217.05%
2022-03-31 Rs21.39 Billion
≈ $231.28 Million
Rs1.70 Billion
≈ $18.40 Million
0.080x -54.17%
2021-03-31 Rs18.13 Billion
≈ $196.12 Million
Rs3.15 Billion
≈ $34.04 Million
0.174x -9.35%
2020-03-31 Rs14.38 Billion
≈ $155.51 Million
Rs2.75 Billion
≈ $29.78 Million
0.191x +47.08%
2019-03-31 Rs14.83 Billion
≈ $160.37 Million
Rs1.93 Billion
≈ $20.88 Million
0.130x +52.83%
2018-03-31 Rs14.44 Billion
≈ $156.20 Million
Rs1.23 Billion
≈ $13.31 Million
0.085x -41.88%
2017-03-31 Rs13.66 Billion
≈ $147.71 Million
Rs2.00 Billion
≈ $21.65 Million
0.147x +14.95%
2016-03-31 Rs10.95 Billion
≈ $118.46 Million
Rs1.40 Billion
≈ $15.10 Million
0.128x +0.15%
2015-03-31 Rs9.95 Billion
≈ $107.59 Million
Rs1.27 Billion
≈ $13.70 Million
0.127x +1049.86%
2014-03-31 Rs10.43 Billion
≈ $112.78 Million
Rs-139.78 Million
≈ $-1.51 Million
-0.013x -116.10%
2013-03-31 Rs10.20 Billion
≈ $110.34 Million
Rs849.32 Million
≈ $9.19 Million
0.083x -90.82%
2012-03-31 Rs9.70 Billion
≈ $104.90 Million
Rs8.80 Billion
≈ $95.14 Million
0.907x +368.67%
2011-03-31 Rs6.92 Billion
≈ $74.79 Million
Rs1.34 Billion
≈ $14.47 Million
0.194x -9.87%
2010-03-31 Rs5.68 Billion
≈ $61.44 Million
Rs1.22 Billion
≈ $13.19 Million
0.215x +10.50%
2009-03-31 Rs4.69 Billion
≈ $50.71 Million
Rs911.05 Million
≈ $9.85 Million
0.194x +210.91%
2008-03-31 Rs4.53 Billion
≈ $48.99 Million
Rs283.11 Million
≈ $3.06 Million
0.062x +17.36%
2007-03-31 Rs4.18 Billion
≈ $45.26 Million
Rs222.82 Million
≈ $2.41 Million
0.053x -21.99%
2006-03-31 Rs3.30 Billion
≈ $35.73 Million
Rs225.51 Million
≈ $2.44 Million
0.068x --

About JB Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$3.55 Billion
Rs328.02 Billion INR
Market Cap Rank
#4460 Global
#189 in India
Share Price
Rs2043.40
Change (1 day)
-0.86%
52-Week Range
Rs1504.40 - Rs2138.60
All Time High
Rs2138.60
About

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage … Read more